Failure of liver function tests in predicting drug clearance of chemotherapeutic agents in a patient who had recovered from hepatic congestion.
Tsubokura
Masaharu
M
Miura
Yuji
Y
Itokawa
Tatsuo
T
Takei
Naoko
N
Higaki
Tadanao
T
Amaki
Toshihiro
T
Ishida
Yasuo
Y
Kusama
Makiko
M
Ono
Shunsuke
S
Narimatsu
Hiroto
H
Kami
Masahiro
M
Komatsu
Tsunehiko
T
D000369:Aged, 80 and over; D000410:Alanine Transaminase / Q000097:blood; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D015415:Biomarkers / Q000097:blood; D004317:Doxorubicin / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000378:metabolism; D008111:Liver Function Tests / Q000592:standards*; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008657:Metabolic Clearance Rate; D011237:Predictive Value of Tests; D014750:Vincristine / Q000009:adverse effects*
D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D015415:Biomarkers; D014750:Vincristine; D004317:Doxorubicin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin